Amid Rotation, I’m Adding to an Obscure Biotech and a Magnificent 7 Stock
Here’s my plan as AI stocks are sliding while money moves into the names that struggled for months, and biotech is leading the way.
Here’s my plan as AI stocks are sliding while money moves into the names that struggled for months, and biotech is leading the way.
Stocks were slammed after a hot core CPI report, but bonds rallied and biotech rose.
A warm inflation number lets the market price in the worst case for the Fed, and biotech is already acting like it has washed out. Here’s my plan.
As biotech is getting hit and we’re seeing ETF-driven selling, I smell opportunity for sharp traders.
Biotech stocks are heating up, as the use of AI technologies accelerates new drug discoveries.
While breadth is strong, new lows still outnumber new highs two to one.
September hike odds jumped on one sentence about underlying inflation from the Federal Reserve chair.
The indices held up on one biotech breakthrough while the Nasdaq lost ground.
The senior indices sold off while the Russell 2000 gained and breadth stayed positive.
The indexes are hiding a lack of market leadership, but I have spotted an energetic trade.